- Home
- CRGY vs INDV Comparison
CRGY vs INDV Comparison
Compare CRGY & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRGY | INDV |
|---|---|---|
| Founded | 1986 | 1994 |
| Country | United States | United States |
| Employees | N/A | 838 |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.2B |
| IPO Year | 2022 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CRGY | INDV |
|---|---|---|
| Price | $13.27 | $35.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 4 |
| Target Price | $17.47 | ★ $49.00 |
| AVG Volume (30 Days) | ★ 5.1M | 1.2M |
| Earning Date | 11-02-2026 | 10-29-2026 |
| Dividend Yield | ★ 3.72% | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | N/A | ★ 1.67 |
| Revenue | ★ $3,579,782,000.00 | $1,239,000,000.00 |
| Revenue This Year | $39.29 | $7.50 |
| Revenue Next Year | N/A | $5.07 |
| P/E Ratio | $99.08 | ★ $21.89 |
| Revenue Growth | ★ 22.14 | 4.29 |
| 52 Week Low | $7.68 | $22.56 |
| 52 Week High | $15.47 | $42.81 |
Technical Indicators
Market Signals| Indicator | CRGY | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 44.05 | 50.10 |
| Support Level | $11.45 | $35.78 |
| Resistance Level | $14.06 | $36.62 |
| Average True Range (ATR) | 0.44 | 0.93 |
| MACD | -0.20 | 0.25 |
| Stochastic Oscillator | 10.07 | 67.98 |
Price Performance
Historical ComparisonAbout CRGY Crescent Energy Company
Crescent Energy Co is an energy company committed to delivering value for shareholders through disciplined growth, acquisition ideas, and the consistent return of capital. Its long-life, balanced portfolio combines stable cash flows from low-decline production with deep, high-quality development inventory. The company operates in one reportable segment, which is the exploration and production of crude oil, natural gas, and NGLs.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).